J. M. Brown & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$836K Sell
3,196
-46
-1% -$11.8K 0.48% 54
2026
Q2
$816K Buy
+3,242
New +$698K 0.47% 66

Other funds holding ABBV

J. M. Brown & Associates's ABBV Position: Q3 2026 in Review

J. M. Brown & Associates reduced its AbbVie (ABBV) stake by 1.4% in Q3 2026, selling an estimated $11.8K and leaving 3,196 shares worth $836K. The position accounts for 0.48% of the portfolio, ranked #54.

J. M. Brown & Associates first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • J. M. Brown & Associates held 3,196 shares of AbbVie worth $836K as of Q3 2026.
  • J. M. Brown & Associates sold 46 AbbVie shares in Q3 2026, an estimated $11.8K.
  • AbbVie made up 0.48% of J. M. Brown & Associates's portfolio in Q3 2026, its #54 holding.
  • J. M. Brown & Associates first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on J. M. Brown & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.